CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: Discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens

American Journal of Neuroradiology

Volumn 34, Issue 7, 2013, Pages 1308-1318

  Post, M J D ^a   Thurnher, M M ^b   Clifford, D B ^c   Nath, A ^d   Gonzalez, R G ^e   Gupta, R K ^f   Post, K K ^g  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^g UMass Memorial Medical Center University Campus ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; CORTICOSTEROID; PREDNISONE;

CANDIDA MENINGITIS; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; CORTICOSTEROID THERAPY; CRYPTOCOCCAL MENINGITIS; CYTOMEGALOVIRUS RETINITIS; HERPES ZOSTER; HERPES ZOSTER ENCEPHALITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SUBARACHNOID SPACE; TOXOPLASMOSIS; TUBERCULOSIS; VARICELLA ZOSTER VIRUS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDIASIS; CENTRAL NERVOUS SYSTEM DISEASES; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CENTRAL NERVOUS SYSTEM INFECTIONS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; TOXOPLASMOSIS, CEREBRAL; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM;

EID: 84880836291     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3184     Document Type: Review

References (79)

1. Johnson T, Nath A. Neurological complications of immune reconstitution in HIV-infected populations. Ann N Y Acad Sci 2010;1184:106-20.
2. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005;19:399-406.
3. Shelburne SA III, Hamill R. The immune reconstitution inflammatory syndrome. AIDS Rev 2003;5:67-79.
4. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006;57:167-70.
5. Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:251-61.
6. Vendrely A, Bienvenu B, Gasnault J, et al. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005;109:449-55.
7. Shelburne SA III, Hamill RJ, Rodriquez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002;81:213-27.
8. Bonham S, Meya DB, Bohjanen PR, et al. Biomarkers of HIV immune reconstitution inflammatory syndrome. Biomark Med 2008;2:349-61.
9. Manabe Y, Campbell JD, Syndor E, et al. Immune reconstitution inflammatory syndrome: risk factors and treatment applications. J Acquir Immune Defic Syndr 2007;46:456-62.
10. Grant PM, Komarow L, Andersen J, et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS ONE 2010; 5:e11416.
11. Dhasmana DJ, Dheda K, Ravn P, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs 2008;68:191-208.
12. French MA. Disorders of immune reconstitution in patients with HIVinfection responding to antiretroviral therapy. Curr HIV/AIDS Rep 2007;4:16-21.
13. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000;1:107-15.
14. French MA. Immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009;48:101-07.
15. Tan K, Roda R, Ostrow L, et al. PML-IRIS in patients with HIV infection. Clinical manifestations and treatment with steroids. Neurology 2009;72:1458-64.
16. Berkeley JL, Nath A, Pardo CA. Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: case report and review of the literature. J Neurovirol 2008;14:267-76.
17. Navas E, Martin-Davilla P, Moreno L, et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Inn Med 2002;162:97-99.
18. Murdoch DM, Venter WDF, Van Rie A, et al. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007;4:1-10.
19. Riedel DJ, Pardo CA, McArthur J, et al. Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Prac Neurol 2006;2:557-65.
20. Bicanic T, Meintjes G, Rebe K, et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009;51:130-34.
21. McCombe JA, Auer RN, Maingat FG, et al. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology. Neurology 2009;72:835-41.
22. Venkataramana A, Pardo CA, McArthur JC, et al. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 2006;67:383-88.
23. Gray F, Bazille C, Biassette-Adle, et al. Central nervous system im-mune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 2005;11:16-22.
24. van der Ven AJ, van Oostenbrugge RJ, Kubat B, et al. Cerebral vasculitis after initiation antiretroviral therapy. AIDS 2002;16:2362-64.
25. Murdoch DM, Venter WDF, Feldman C, et al. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008;22:601-10.
26. Robertson J, Meier M, Wall J, et al. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infec Dis 2006;42:1639-46.
27. Stoll M, Schmidt RE. Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. Curr HIV/AIDS Rep 2004;1:122-27.
28. Singer EJ, Sueiras-Valdes M, Commins D, et al. Neurologic presentations of AIDS. Neurol Clin 2010;28:253-75.
29. Sexton DJ, Pien BC, et al. Immune reconstitution inflammatory syndrome. UpToDate. Available at http://www.uptodate.com. Accessed January 31, 2012.
30. McCarthy M, Nath A. Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS). Curr Neurol Neurosci Rep 2010;10:467-75.
31. McArthur JC, Steiner J, Sacktor N, et al. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 2010;67:699-714.
32. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000;133:447-54.
33. French MA, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992;6:1293-97.
34. Ohta K, Kishida S. Immune reconstitution inflammatory syndrome in the central nervous system. Brain Nerve 2007;59:1355-62.
35. Rushing EJ, Liappis A, Smirniotopoulos JD, et al. Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity. J Neuropathol 2008;67:819-27.
36. Nath A, Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 1998;54:19-33.
37. Navdeesh S, McCutchan JA. Unmasking of PML by HAART: unusual clinical features and the role of IRIS. J Neuroimmunol 2010;219:100-04.
38. Teo EC, Azwra A, Jones R, et al. Guillain-Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection. J HIV Ther 2007;12:62-63.
39. Anthony IC, Bell JE. Neuropathological findings associated with long-term HAART. In: Paul RH, Sacktor NC, Valcour V, et al, eds. HIV and the Brain. New Challenges in the Modern Era. New York: Humana Press; 2009:29-47.
40. Bazille GF, BiassetteMH, Moulignier A, et al. Central nervous system immunereconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 2005;3:16-22.
41. Ratnam I, Chiu C, Kandala NB, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418-27.
42. Huruy K, Andargachew M, Getahun M, et al. Immunereconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia. J Infect Dis 2008;61:205-09.
43. Gray F, Chrétien F, Vallat-Decouvelaere AV, et al. The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 2003;62:429-40.
44. Price P, Morahan G, Huang D, et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002;16:2043-47.
45. Wang ME, Castillo ME, Silvia M, et al. Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru. Pediatr Infect Dis J 2009;28:900-03 46.
46. Kilborn T, Zampoli M. Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIVinfected children. Pediatr Radiol 2009;39:569-74.
47. Newsome SD, Nath A. Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol 2009;15:288-91.
48. Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster vasculopathies: clinical, CSF, imaging and virologic features. Neurology 2008;70:853-59.
49. Nanavati KI, Post MJ, Nagornaya N. Value ofMRIin the diagnosis of clinically elusive herpes zoster myelitis in HIV-positive patients. In: Proceedings of the American Society of Spine Radiology Annual Symposium, Miami Beach, Florida. February 18-22, 2009.
50. Espinosa E, Pena-Jimenez A, Ormsby CE, et al. Later onset of herpes zoster-associatedimmunereconstitution inflammatory syndrome. HIV Med 2009;10:454-57.
51. Steininger C, Puchhammer-Stocki E, Popow-Kraupp. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). J Clin Virol 2006;37:1-9.
52. Karavellas MP, Lowder CY, MacDonald C, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998;116:169-75.
53. Jacobson MA, Zegans, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-45.
54. Anderson AM, Mosunjac MB, Corey AS, et al. Simultaneous typical and extraordinary imaging findings of AIDS-associated cytomegalovirus encephalitis. J Neurol Sci 2011;307:174-77.
55. Anderson AM, Fountain JA, Green SB, et al. Human immunodeficiency virus-associated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution. J Neurovirol 2010;16:179-84.
56. Morgello S. Cho ES, Nielsen S, et al. Cytomegalovirus encephalitis in patients with the acquired immunodeficiency syndrome: an autopsy of 30 cases and a review of the literature. Hum Pathol 1987;18:289-97.
57. Melica G, Brugieres P, Lascaux AS, et al. Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era. J Med Virol 2009;81:578-81.
58. Thurnher MM, Schindler EG, Thurnher SA, et al. Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MRI imaging findings and clinical course. AJNR Am J Neuroradiol 2000;21:670-78.
59. Miller RF, Issacson PG, Hall-Craggs M, et al. Cerebral CD8 lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 2004;108:17-23.
60. Langford TD, Letendre SL, Marcotte TD, et al. Severe demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002;16:1019-29.
61. Tavazzi E, Bargiggia V, Pichiecchio A, et al. HIV-related acute inflammatory leukoencephalopathy of undetermined origin: review of the literature. Int J Immunopathol Pharmacol 2010;23:693-700.
62. Kishida S, Ajisawa A. Probable cerebral mycobacterium avium complex- related immune reconstitution inflammatory syndrome in an HIV-infected patient. Intern Med 2008;47:1349-54.
63. Mohanty K. Immune reconstitution inflammatory syndrome after initiation of highly active anti-retroviral therapy in HIV/AIDS. Indian J Dermatol Venereol Leprol 2010;76:301-04.
64. Murray R, Mallal S, Heath C, et al. Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection. Eur J Clin Microbiol Infect Dis 2001;20:199.
65. Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004;39:1709-12.
66. Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009;48:e96-107.
67. Marais S, Pepper DJ, Marais B, et al. HIV-associated tuberculous meningitis: diagnostic and therapeutic challenges. Tuberculosis (Edinb) 2010;90:364-74.
68. Thwaites GE, Macmullen-Price J, Tran TH, et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007;6:230-36.
69. Whiteman M, Espinoza L, Post MJ, et al. CNS tuberculosis in HIVinfected patients: clinical and radiographic findings. AJNR Am J Neuroradiol 1995;16:1319-27.
70. Tsambiras PE, Larkin JA, Houston SH. Case report: toxoplasma encephalitis after initiation of HAART. AIDS Read 2001;11:615-16.
71. Ledergerber B, Egger M, Erard V, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV cohort study. JAMA 1999;282:2220-26.
72. Balkhair A, Ahamed S, Sankhla D. Unmasking immune reconstitution inflammatory syndrome (IRIS): A report of five cases and review of the literature. Sultan Qaboos Univ Med J 2011;11:95-103.
73. Tremont-Lukats IW, Garciarena P, Juarbe R, et al. The immune inflammatory reconstitution syndrome and central nervous system toxoplasmosis. Ann Intern Med 2009;150:656-57.
74. Pfeffer G, Prout A, Hooge J, et al. Biopsy-proven immune reconstitution syndrome in a patient with AIDS and cerebral toxoplasmosis. Neurology 2009;73:321-22.
75. Rodriguez RR, Sorlano V, Dona C, et al. Opportunistic infections shortly after beginning highly active antiretroviral therapy. Antivir Ther 1998;3:229-31.
76. Martin-Blondel G, Alvarez M, Delobel P, et al. Toxoplasmic encephalitis IR IS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry 2010;8:691.
77. Costello DJ, Gonzalez RG, Frosch MP. Case 18-2011: a 35-year-old HIV-positive woman with headache and altered mental status. N Engl J Med 2011;364:2343-52.
78. Lindzen E, Jewells V, Bouldin T, et al. Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy. J Neurovirol 2008;14:569-73.
79. Oelschlaeger C, Dziewas R, Reichelt D, et al. Severe leukoencephalopathy with fulminant cerebral edema reflecting immune reconstitution inflammatory syndrome during HIV infection: a case report. J Med Case Reports 2010;4:214-16.